| Description | 1. Isoquercetin (3-Glucosylquercetin) is a potential stimulator of bone mineralization used for prophylaxis of osteoporotic disorders. 2. Isoquercetin may be as a potential therapeutic agent against neurodegeneration in Parkinson's disease. 3. Isoquercetin is an inhibitor of Wnt/β-catenin and may be as a potential novel anti-tumoral agent, such as against human pancreati,liver cancer related to opioid receptors and to the activation of the mitogen-activated protein kinase (MAPK) signalling pathway. . |
| Synonyms | 3-Glucosylquercetin, Hirsutrin, Isoquercitrin, 异槲皮苷, Quercetin 3-o-glucopyranoside, 槲皮素-3-葡萄糖苷 |
| molecular weight | 464.38 |
| Molecular formula | C21H20O12 |
| CAS | 482-35-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 83 mg/mL (178.74 mM) |
| References | 1. Isoquercitrin and polyphosphate co-enhance mineralization of human osteoblast-like SaOS-2 cells via separate activation of two RUNX2 cofactors AFT6 and Ets1[J]. Biochemical Pharmacology, 2014, 89(3):413-421. |